These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38174395)

  • 1. [Therapeutic applications of classical serotonergic psyche-delics: neurobiological mechanisms and neural networks].
    Seynaeve M; Van Besien A; van Elk M
    Tijdschr Psychiatr; 2023; 65(10):613-618. PubMed ID: 38174395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classic Psychedelic Drugs: Update on Biological Mechanisms.
    Vollenweider FX; Smallridge JW
    Pharmacopsychiatry; 2022 May; 55(3):121-138. PubMed ID: 35079988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors.
    Ponomarenko P; Seragnoli F; Calder A; Oehen P; Hasler G
    J Psychopharmacol; 2023 Jul; 37(7):660-678. PubMed ID: 36855289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelics action and schizophrenia.
    Maćkowiak M
    Pharmacol Rep; 2023 Dec; 75(6):1350-1361. PubMed ID: 37899392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.
    Kraehenmann R
    Curr Neuropharmacol; 2017; 15(7):1032-1042. PubMed ID: 28625125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the 5-HT
    Cameron LP; Benetatos J; Lewis V; Bonniwell EM; Jaster AM; Moliner R; Castrén E; McCorvy JD; Palner M; Aguilar-Valles A
    J Neurosci; 2023 Nov; 43(45):7472-7482. PubMed ID: 37940583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review.
    van Elk M; Yaden DB
    Neurosci Biobehav Rev; 2022 Sep; 140():104793. PubMed ID: 35878791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
    Mertens LJ; Preller KH
    Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of psychedelics for the treatment of Alzheimer's disease and related dementias.
    Winkelman MJ; Szabo A; Frecska E
    Eur Neuropsychopharmacol; 2023 Nov; 76():3-16. PubMed ID: 37451163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Psychedelics Facilitate Emergence of Unconscious Psychological Processes?
    Lindegaard T
    Psychodyn Psychiatry; 2023 Sep; 51(3):270-286. PubMed ID: 37712665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review.
    DiVito AJ; Leger RF
    Mol Biol Rep; 2020 Dec; 47(12):9791-9799. PubMed ID: 33231817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
    Vollenweider FX; Kometer M
    Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards an understanding of psychedelic-induced neuroplasticity.
    Calder AE; Hasler G
    Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.
    Garcia-Romeu A; Richards WA
    Int Rev Psychiatry; 2018 Aug; 30(4):291-316. PubMed ID: 30422079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.
    Domanegg K; Sommer WH; Meinhardt MW
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Brief Historical Overview of Psychedelic Research.
    Geyer MA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):464-471. PubMed ID: 38000715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.
    Erritzoe D; Smith J; Fisher PM; Carhart-Harris R; Frokjaer VG; Knudsen GM
    J Psychopharmacol; 2019 Sep; 33(9):1068-1075. PubMed ID: 30816797
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.